Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study

Authors:	Daniel M. Moreira MD J. Curtis Nickel MD Leah Gerber MSc Roberto L. Muller MD Gerald L. Andriole MD Ramiro Castro‐Santamaria MD Stephen J. Freedland MD

Affiliation:	1. The Arthur Smith Institute for Urology, North Shore Long Island Jewish Health System, New Hyde Park, New York;2. Department of Urology, Queen's University, Kingston, Ontario, Canada;3. Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina;4. Urology Section, Veterans Affairs Medical Center, Durham, North Carolina;5. Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri;6. GlaxoSmithKline Inc, Metabolic Pathways and Cardiovascular Research and Development Unit, King of Prussia, Pennsylvania;7. Department of Pathology, Duke University School of Medicine, Durham, North Carolina

Abstract:

Keywords:	inflammation prostate cancer prostatic neoplasm prostate‐specific antigen prostatitis